Trends and outcomes of cardiac transplantation from donors dying of drug intoxication - 12/05/18
, Di Lu, PhD b, Stacy Cobb, PhD b, Lauren B. Cooper, MD, MHS a, c, Adam DeVore, MD, MHS a, b, Chetan B. Patel, MD a, Paul B. Rosenberg, MD a, Jacob N. Schroder, MD d, Mani A. Daneshmand, MD d, Carmelo A. Milano, MD d, Adrian F. Hernandez, MD, MHS a, b, Joseph G. Rogers, MD a, b, Robert J. Mentz, MD a, bAbstract |
Background |
Deaths from drug intoxication have increased in the United States but outcomes of recipients of orthotopic heart transplantation (OHT) from these donors are not well characterized.
Methods |
We performed a retrospective analysis of the United Network for Organ Sharing's STAR database between January 2000 and March 2014 and assessed mortality and retransplantation using adjusted Cox models by mechanism of donor death.
Results |
Of the 31,660 OHTs from 2000 to 2014, 1233 (3.9%) were from drug intoxication. These donors were more likely to be female, white, with greater tobacco use and higher BMI compared to donors who died of other mechanisms. Drug intoxication accounted for 1.1% of OHT donors in 2000 and 6.2% in March 2014. No significant difference was observed in 10-year mortality (adjusted hazard ratio [HR], 95% confidence interval [CI]: 0.99, 0.87-1.13), 10-year retransplantation (adjusted HR 0.84, 0.49-1.41) or 1-year and 3-year rehospitalization with other mechanisms of death compared to drug intoxication.
Conclusion |
There has been a large increase in OHT donors who die of drug intoxication in the United States. OHT outcomes from these donors are similar to those dying from other mechanisms. These data have important implications for donor selection in context of the ongoing opioid epidemic.
Le texte complet de cet article est disponible en PDF.Abbreviations : HBV, HCV, HIV, OHT, OPTN, UNOS
Plan
| Hartzell V. Schaff, MD served as guest editor for this article. |
Vol 199
P. 92-96 - mai 2018 Retour au numéro
Article précédent
- Resource utilization and outcome among patients with selective versus nonselective troponin testing
- Alex R. Campbell, Alexander J. Rodriguez, David M. Larson, Craig E. Strauss, Ross F. Garberich, Matthew F. Partridge, Timothy D. Henry, Scott W. Sharkey
- Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial
- Andrew P. Ambrosy, Ankeet S. Bhatt, Amanda L. Stebbins, Lisa M. Wruck, Marat Fudim, Stephen J. Greene, William E. Kraus, Christopher M. O'Connor, Ileana L. Piña, David J. Whellan, Robert J. Mentz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?